| Christopher Dahle, DPT | |
|
1615 Curlew Dr, Ammon, ID 83406-4718 | |
| (208) 516-1204 | |
| (208) 577-6744 |
| Full Name | Christopher Dahle |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 1615 Curlew Dr, Ammon, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649761727 | NPI | - | NPPES |
| PT-5535 | Other | ID | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-5535 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rigby Physical Therapy Pllc | 5395982888 | 3 |
News Archive
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Health care costs are among the top economic problems experienced by U.S. residents, according to a poll released on Tuesday by the Kaiser Family Foundation, the Los Angeles Times reports. For the poll, a nationally representative sample of 2,003 adults was interviewed by telephone between April 3 and 13. The poll has a margin of sampling error of plus or minus three percentage points.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Provider Name | Wright Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922279785 PECOS PAC ID: 0840367561 Enrollment ID: O20080923000205 |
News Archive
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Health care costs are among the top economic problems experienced by U.S. residents, according to a poll released on Tuesday by the Kaiser Family Foundation, the Los Angeles Times reports. For the poll, a nationally representative sample of 2,003 adults was interviewed by telephone between April 3 and 13. The poll has a margin of sampling error of plus or minus three percentage points.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Provider Name | Rigby Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952642373 PECOS PAC ID: 5395982888 Enrollment ID: O20130430000254 |
News Archive
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Health care costs are among the top economic problems experienced by U.S. residents, according to a poll released on Tuesday by the Kaiser Family Foundation, the Los Angeles Times reports. For the poll, a nationally representative sample of 2,003 adults was interviewed by telephone between April 3 and 13. The poll has a margin of sampling error of plus or minus three percentage points.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Provider Name | Wright Physical Therapy Limited Partnership |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1730732025 PECOS PAC ID: 1759612641 Enrollment ID: O20191007003583 |
News Archive
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Health care costs are among the top economic problems experienced by U.S. residents, according to a poll released on Tuesday by the Kaiser Family Foundation, the Los Angeles Times reports. For the poll, a nationally representative sample of 2,003 adults was interviewed by telephone between April 3 and 13. The poll has a margin of sampling error of plus or minus three percentage points.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Dahle, DPT 1411 Falls Ave E Ste 415, Twin Falls, ID 83301-3455 Ph: (208) 969-9945 | Christopher Dahle, DPT 1615 Curlew Dr, Ammon, ID 83406-4718 Ph: (208) 516-1204 |
News Archive
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Health care costs are among the top economic problems experienced by U.S. residents, according to a poll released on Tuesday by the Kaiser Family Foundation, the Los Angeles Times reports. For the poll, a nationally representative sample of 2,003 adults was interviewed by telephone between April 3 and 13. The poll has a margin of sampling error of plus or minus three percentage points.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 8 days ago
Brittany Renae Brown, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1615 Curlew Dr, Ammon, ID 83406 Phone: 208-516-1204 Fax: 208-577-6477 | |
Peak Performance Therapy Services P C Physical Therapist Medicare: Medicare Enrolled Practice Location: 3456 E 17th St, Suite 130, Ammon, ID 83406 Phone: 208-523-0030 Fax: 208-523-3828 | |
Phares Briggs Horman, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3456 E 17th St, Suite 130, Ammon, ID 83406 Phone: 208-523-0030 | |
Vista Physical Therapy, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1615 Midway Dr, Ammon, ID 83406 Phone: 208-529-1715 | |
Michael Cuthbertson, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3456 E 17th St Ste 130, Ammon, ID 83406 Phone: 208-523-0030 Fax: 208-523-3828 | |
Achieve Therapy And Learning Services, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1979 Eagle Pointe Ct, Ammon, ID 83406 Phone: 208-589-8381 | |
Lindsay Ann Rankin, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2785 Eagle Dr Apt G106, Ammon, ID 83406 Phone: 801-602-2651 |